Differentiation between multiple sclerosis and neuromyelitis optica spectrum disorder using a deep learning modelJin Myoung Seok, Ju‐Hong Min, Wanzee Cho et al.|Scientific Reports|2023Cited by 37
Time to Treat First Acute Attack of Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseYoung Nam Kwon, Sung Min Kim, Boram Kim et al.|JAMA Neurology|2024Cited by 26
Risk of depression and anxiety in multiple sclerosis and neuromyelitis optica spectrum disorder: A nationwide cohort study in South KoreaSoonwook Kwon, Ju‐Hong Min, Hea Lim Choi et al.|Multiple Sclerosis Journal|2024Cited by 12
Novel index, neutrophil percentage (%) is a useful marker for disease activity in MOG antibody-associated diseaseSong-Ik Baek, Ju‐Hong Min, Suho Ro et al.|Multiple Sclerosis and Related Disorders|2023Cited by 12
Evaluating Rituximab Failure Rates in Neuromyelitis Optica Spectrum Disorder: A Nationwide Real-World Study From South KoreaSu‐Hyun Kim, Ho Jin Kim, Ju‐Hong Min et al.|Journal of Clinical Neurology|2025Cited by 11